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Abstract  15 
Shigella infection in epithelial cells induces cell death which is accompanied by mitochondrial 16 
dysfunction. In this study the role of the mitochondrial fission protein, Drp1 during Shigella 17 
infection in HeLa cells was examined. Significant lactate dehydrogenase (LDH) release was 18 
detected in the culture supernatant when HeLa cells were infected with Shigella at a high 19 
multiplicity of infection. Drp1 inhibition with Mdivi-1 and siRNA knockdown significantly 20 
reduced LDH release. HeLa cell death was also accompanied by mitochondrial fragmentation. 21 
Tubular mitochondrial networks were partially restored when Drp1 was depleted with either 22 
siRNA or inhibited with Mdivi-1. Surprisingly either Mdivi-1 treatment or Drp1 siRNA-23 
depletion of HeLa cells also reduced Shigella plaque formation. The effect of Mdivi-1 on 24 
Shigella infection was assessed using the murine Sereny model, however it had no impact on 25 
ocular inflammation. Overall our results suggest that Drp1 and the mitochondria play important 26 
roles during Shigella infection. 27 
 28 
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Shigella flexneri is the causative agent of bacillary dysentery (shigellosis) and is a significant 38 
human pathogen due to its high morbidity among children < 5 years in developing countries 39 
(Bardhan et al., 2010). The key pathogenic features of Shigella include cell death induction in 40 
myeloid immune cells and circumventing cell death in colonic epithelial cells, the site of Shigella 41 
infection. Shigella also interact with host proteins to initiate de novo actin synthesis to facilitate 42 
its intra- and intercellular spread to disseminate within the colon. 43 
 44 
Post ingestion of contaminated food and water, Shigella initially invades the host intestinal 45 
epithelium via microfold cells and induce pyroptosis of the resident macrophages in the follicle 46 
associated epithelium by activating ICE protease-activating factor-dependent (IPAF/NLRC4) 47 
and apoptosis-associated speck-like protein containing caspase recruitment domain (ASC) 48 
inflammasome (Senerovic et al., 2012; Suzuki et al., 2007). Subsequent caspase-1 activation 49 
releases interleukin-1β (IL-1β) and interleukin-18 (IL-18), resulting in strong inflammatory 50 
responses and magnified innate responses, respectively (Sansonetti et al., 2000). Another form of 51 
necrotic cell death induced in macrophage is pyronecrosis, which is independent of caspase-1 52 
activation and releases another proinflammatory factor, HMGB1 (high-mobility group box 1 53 
protein) (Willingham et al., 2007).  54 
 55 
Following macrophage pyroptosis, Shigella are released into the basolateral compartment and 56 
invade enterocytes via the type three secretion system (TTSS), followed by lysis of the endocytic 57 
vacuole and replication in the cytoplasm (Cossart and Sansonetti, 2004; Sansonetti et al., 1986). 58 
The polarly localised Shigella IcsA protein interacts with the host N-WASP (Neural Wiskott-59 
Aldrich syndrome protein) and Arp2/3 complex to initiate F-actin nucleation and polymerisation, 60 
leading to actin based motility which allows the bacterium to spread within the cytoplasm and 61 
also laterally via protrusion formation into the adjacent cells (Bernardini et al., 1989; Lett et al., 62 
1989; Makino et al., 1986). After escaping from the double membrane vacuole, subsequent 63 
cycles of infection are initiated (Schuch et al., 1999). Proteins localised at the enterocyte tight 64 
junctions and adherens junctions facilitate Shigella protrusion formation and may associate 65 
directly with the Shigella actin tail (Bishai et al., 2012; Kadurugamuwa et al., 1991; Sansonetti et 66 











al., 1994). Shigella invasion and dissemination is also dependent on ATP release by connexion 67 
26 and formins, Dia1 and Dia2, which can initiate de novo actin polymerisation and crosslink 68 
actin filaments (Heindl et al., 2009; Tran Van Nhieu et al., 2003). Components of the clathrin 69 
mediated endocytosis pathway also facilitate Shigella entry into the adjacent cell (Fukumatsu et 70 
al., 2012; Lum et al., 2013). 71 
 72 
Eliminating infected enterocytes prevents Shigella from propagating and disseminating into 73 
uninfected cells (Ashida et al., 2011). However Shigella is able to delay cell death by 74 
manipulating host signalling pathways. Depending on the experimental conditions such as host 75 
cell type, time of infection and multiplicity of infection (moi), apoptotic and necrotic cell death 76 
have been observed during Shigella infection. Apoptosis is a non-inflammatory cell death which 77 
is activated by mitochondria and death receptor mediated pathways characterised by caspase 78 
activation, DNA fragmentation, cell shrinkage, membrane blebbing and mitochondrial 79 
permeability (Lamkanfi and Dixit, 2010), whereas necrosis is characterised by nuclear swelling, 80 
membrane rupture and spillage of cellular contents into the environment resulting in 81 
inflammatory conditions. Absence of caspase activation, reactive oxygen species (ROS) 82 
production, lysosomal destabilization, calpain release and ATP depletion are also observed 83 
(Golstein and Kroemer, 2007; Vandenabeele et al., 2010).  84 
 85 
Shigella infection in HeLa cells induces an early genotoxic stress (Bergounioux et al., 2012). 86 
The tumour suppressor protein p53, an inducer of apoptosis is normally stabilised during 87 
genotoxic response. However p53 is rapidly degraded by calpain, through degradation of the 88 
calpain protease inhibitor, calpastatin, by the Shigella VirA TTSS effector (Bergounioux et al., 89 
2012). Calpain activation inadvertently activates the necrosis pathway which restricts Shigella 90 
intracellular growth (Bergounioux et al., 2012). In the colonic HCT116 cells, the slow 91 
degradation of p53 shifts the executing pathway from necrosis to apoptosis (Bergounioux et al., 92 
2012). In HaCat (immortalized keratinocytes) cells, the Shigella TTSS effector, OspC3 targets 93 
the p19 subunit of Caspase-4 to delay necrotic cell death (Kobayashi et al., 2013). In vivo the 94 
∆ospC3 mutant exacerbates colonic inflammation in guinea pigs (Kobayashi et al., 2013). In 95 
HeLa cells and mouse embryonic fibroblasts (MEFs), pro-survival Nod1/NF-кB/Bcl-2 signalling 96 
is activated to counteract the necrotic pathway mediated by Bnip3, a regulator of mitochondrial 97 











permeability transition during Shigella infection (Carneiro et al., 2009). In staurosporine (STS)-98 
induced apoptosis in HeLa cells, the Shigella Spa15 (TTSS) effector prevented caspase-3 99 
activation (Faherty and Maurelli, 2009). Shigella infection in HeLa cells and in an ex vivo 100 
colonic epithelial cell model reportedly triggered apoptosis via caspase-9 and caspase-3 101 
activation (Lembo-Fazio et al., 2011). Furthermore Gadd45a (stress sensor growth arrest and 102 
DNA damage 45a), a stress-inducible gene, was also upregulated in vitro and ex vivo (Lembo-103 
Fazio et al., 2011). 104 
 105 
Mitochondrial fission is an important downstream event for intrinsic apoptotic and programmed 106 
necrosis signalling pathways (Otera et al., 2013). Mitochondrial constriction is initially mediated 107 
by the endoplasmic reticulum and actin (Friedman et al., 2011; Korobova et al., 2013). Dimeric 108 
or tetrameric cytosolic dynamin-related protein 1 (Drp1, also known as dynamin-1-like protein) 109 
is then recruited to fission sites on the mitochondria to its receptor, Mff (Otera et al., 2010). In 110 
the presence of GTP, Drp1 self-assembly stimulates GTP hydrolysis and formation of higher 111 
order structures as foci at the mitochondrial fission sites (Smirnova et al., 2001). Oligomerised 112 
Drp1 wraps around the mitochondria and following GTP hydrolysis, the mitochondrial 113 
membrane is severed (Smirnova et al., 2001). Drp1 assembly on the mitochondria is inhibited by 114 
the small molecule inhibitor, mitochondrial division inhibitor-1 (Mdivi-1) through interactions 115 
with an allosteric site which does not affect its GTPase activity (Cassidy-Stone et al., 2008). 116 
Mdivi-1 has therapeutic effects in various animal models of non-infectious diseases (Ferrari et 117 
al., 2011; Ong et al., 2010; Tang et al., 2013).   118 
 119 
Previously we reported that dynasore, an inhibitor of dynamin II and Drp1 GTPase activity 120 
affected Shigella cell spreading and Shigella-induced cytotoxicity in HeLa cells. Furthermore 121 
dynasore also protected mice from weight loss in an ocular infection model even though 122 
inflammation was not reduced (Lum et al., 2013). We decided to investigate if Drp1 contributed 123 
to the observations we made earlier. In this study HeLa cells were infected with Shigella at a moi 124 
(multiplicity of infection) of 500 and 1000. During Shigella infection, lactate dehydrogenase 125 
(LDH) was released into the culture supernatant. HeLa cells treated with a pan-caspase inhibitor 126 
did not reduce LDH release and caspase-3 was not activated, suggesting Shigella induces non-127 
apoptotic cell death under these conditions. Drp1 inhibition with Mdivi-1 and Drp1 depletion 128 











with siRNA reduced LDH release. Mitochondrial fragmentation was also observed in Shigella-129 
infected cells and was partially restored when HeLa cells were either treated with Mdivi-1 or 130 
when Drp1 was depleted with siRNA. Unexpectedly Shigella plaque formation was reduced in 131 
Mdivi-1-treated HeLa cells. This was also observed in HeLa cells knockdown with Drp1 siRNA, 132 
suggesting maintaining mitochondria structure is important for efficient cell spreading. A murine 133 
Sereny test was used to determine if Mdivi-1 could reduce keratoconjunctivitis or protect mice 134 
from weight loss due to Shigella infection. Mdivi-1 treatment did not reduce ocular inflammation 135 
but did protect mice from weight loss in the first 24 h only. These results suggest Drp1 and the 136 
mitochondria are critical for Shigella infection. 137 
 138 
Materials and methods 139 
Bacterial strains and growth media  140 
The strains used in this study are listed in Table 1. S. flexneri strains were grown from a Congo 141 
Red positive colony as described previously (Morona et al., 2003) and were routinely cultured in 142 
Luria Bertani (LB) broth and on LB agar. Virulence plasmid-cured (VP¯) derivative of WT S. 143 
flexneri strain was isolated on Congo Red agar as white colonies and re-streaked until pure 144 
(Morona and Van Den Bosch, 2003). Bacteria were grown in media for 16 h with aeration, 145 
subcultured 1/20 and then grown with aeration to mid-exponential growth phase for 1.5 h at 146 
37°C. Where appropriate, media were supplemented with tetracycline (4 or 10 μg/mL). 147 
 148 
Chemicals and antibodies  149 
IM-54 (5 mM stock - ALX-430137; Enzo Life Sciences), Mdivi-1 (50 mM stock - M0199; 150 
Sigma-Aldrich, BML-CM127; Enzo Life Sciences), Necrostatin-1 (100 mM stock - N9037; 151 
Sigma-Aldrich), Necrostatin-7 (20 mM stock - ALX-430-170; Enzo Life Sciences), 152 
Necrosulfonamide (20 mM stock - N388600; Toronto Research Chemicals), NecroX-2 (5 mM 153 
stock - ALX-430-166; Enzo Life Sciences), NecroX-5 (5 mM stock - ALX-430-167; Enzo Life 154 
Sciences), Staurosporine (10 mM stock - 00025, Biotium), Z-FA-FMK (20 mM stock - 550411; 155 
BD Biosciences) and Z-VAD-fmk (20 mM stock - Merck Calbiochem; 627610) were prepared in 156 
dimethyl sulfoxide (DMSO) (D2650; Sigma-Aldrich) for in vitro studies. For in vivo studies, 157 
Mdivi-1 was dissolved in a formulation containing 1-methyl-2-pyrrolidione (NMP/Pharmasolve; 158 
Ashland ISP) and polyethylene glycol 300 (PEG300; Sigma-Aldrich) (1 part NMP to 9 parts 159 











PEG300). Mdivi-1 was prepared as a 22 mg/mL stock and diluted 1/4 (5.5 mg/mL) with 160 
NMP/PEG before injection into mice. Mouse anti-DLP1 antibody (611112; BD Biosciences) and 161 
rabbit anti-GAPDH antibody (600-401-A33; Rockland Immunochemicals, Inc.) were used at 162 
1:100 and 1:3000 for Western immunoblotting, respectively. For immunofluorescence (IF) 163 
microscopy, rabbit anti-active (cleaved) caspase-3 antibody (AB3623; Merck Milipore), anti-164 
DLP1 antibody, Alexa 594-conjugated donkey anti-mouse secondary antibody and Alexa Fluor 165 
594-conjugated donkey anti-rabbit antibody (Molecular Probes) were used at 1:100.  166 
 167 
Reverse transfection and HeLa cell lysate preparation  168 
DNM1L siRNA (L012092-00-0005) and siRNA controls (Non-targeting Pool; D-001810-10-05, 169 
siGLO Green Transfection Indicator; D-001630-01-05) were purchased from Thermo Scientific. 170 
siRNAs were transfected with DharmaFECT 3 Transfection Reagent (T-2003-03) and 171 
DharmaFECT Cell Culture Reagent (DCCR; B-004500-100), also purchased from Thermo 172 
Scientific. Reverse transfection of HeLa cells (Human, cervical, epithelial cells ATCC #CCL-70) 173 
were carried out based on a method by Thermo Scientific. siRNA were prepared as a 5 µM stock 174 
and the final concentration used was 50 nM. HeLa cells were transfected and cell lysates were 175 
prepared as described previously (Lum et al., 2013).  176 
 177 
SDS-PAGE and Western immunoblotting  178 
SDS-PAGE (12% acrylamide gel) and Western immunoblotting were carried out as described 179 
previously (Lum et al., 2013). Molecular weight markers used were BenchMark™ Pre-Stained 180 
Protein Ladder (Invitrogen). 181 
 182 
Plaque assay  183 
Plaque assays were performed with HeLa cells as described previously by Oaks et al. (Oaks et 184 
al., 1985) with modifications. HeLa cells were transfected in 12-well trays prior to plaque assay 185 
as described previously (Lum et al., 2013). On day 4, the plaque assay was carried out when the 186 
cells reached confluency. HeLa cells were washed twice with Dulbecco’s modified Eagle 187 
medium (DMEM) prior to inoculation. 5 × 104 mid-exponential phase bacteria were added to 188 
each well. Trays were incubated at 37°C, 5% CO2 and were rocked gently every 15 min to 189 
spread the inoculum evenly across the well. At 90 min post infection, the inoculum was 190 











aspirated. 0.5 mL of the first overlay (DMEM, 5% FCS, 20 µg/mL gentamicin, 0.5% (w/v) 191 
agarose [Seakem ME]) was added to each well. The second overlay (DMEM, 5% FCS, 20 192 
µg/mL gentamicin, 0.5% (w/v) agarose, 0.1% (w/v) Neutral Red solution [Gibco BRL]) was 193 
added 24 h post infection and plaques were imaged 6 h later. All observable plaques were 194 
counted and the diameter was measured for each condition in each experiment. At least 50 195 
plaques were measured for each condition. 196 
 197 
Infectious focus assay  198 
1.2 × 106 HeLa cells were seeded in six-well trays in minimal essential medium (MEM), 10% 199 
FCS, 1% penicillin/streptomycin. Cells were grown to confluence overnight and were washed 200 
twice with DMEM prior to inoculation. 5 × 104 mid-exponential phase bacteria expressing 201 
mCherry were added to each well. Trays were incubated at 37°C, 5% CO2 and were rocked every 202 
15 min to spread the inoculum evenly across the well. At 90 min post infection, the inoculum 203 
was aspirated. 1.5 mL of DMEM (phenol red-free) (31053-028; Life Technologies), 1 mM 204 
sodium pyruvate, 5% FCS, 20 µg/mL gentamicin, 2 mM IPTG was added to each well. Mdivi-1 205 
or DMSO were added and were swirled to ensure even distribution. 24 h later the infectious foci 206 
were imaged with an Olympus IX-70 microscope using a 10× objective. The filter set used was 207 
DA/FI/TX-3X-A-OMF (Semrock). Fluorescence and phase contrast images were captured and 208 
false colour merged with the Metamorph software program (Version 7.7.3.0, Molecular 209 
Devices). The area of the infectious focus, i.e. area where mCherry was expressed, was outlined 210 
and measured with Metamorph. All observable infectious foci were counted and the area was 211 
measured for each condition in each experiment. At least 5 infectious foci were measured for 212 
each condition. 213 
 214 
Invasion assay and IF microscopy 215 
HeLa cells (8 × 104) were seeded onto sterile glass cover slips in 24-well trays in MEM, 10% 216 
FCS, 1% penicillin/streptomycin. For transfected cells, HeLa cells were transfected as described 217 
previously (Lum et al., 2013). Cells were grown to semi-confluence overnight, washed twice 218 
with Dulbecco’s PBS (D-PBS) and once with MEM, 10% FCS. 4 × 107 mid-exponential phase 219 
bacteria were added to each well and subsequently centrifuged (2,000 rpm, 7 min, Heraeus 220 
Labofuge 400 R) onto HeLa cells. After 1 h incubation at 37°C, 5% CO2, the infected cells were 221 











washed thrice with D-PBS and incubated with 0.5 mL MEM containing 40 µg/mL of gentamicin 222 
for a further 1.5 h (or 3.5 h for labelling with anti-activated caspase-3). Infected cells were 223 
washed thrice in D-PBS, fixed in 3.7% (v/v) formalin for 15 min, incubated with 50 mM NH4Cl 224 
in D-PBS for 10 min, followed by permeabilisation with 0.1% Triton X-100 (v/v) for 5 min. 225 
After blocking in 10% FCS in PBS, the infected cells were incubated at 37°C for 30 min with the 226 
desired primary antibody. After washing in PBS, coverslips were incubated with either Alexa 227 
Fluor 594-conjugated donkey anti-mouse or Alexa 594-conjugated donkey anti-rabbit secondary 228 
antibody (Molecular Probes) (1:100). F-actin was visualised by staining with Alexa Fluor 488-229 
conjugated phalloidin (2 U/mL) and 4’,6’-diamidino-2-phenylindole (DAPI) (10 μg/mL) was 230 
used to counterstain bacteria and HeLa cell nuclei. Coverslips were mounted on glass slides with 231 
Mowiol 4-88 (Calbiochem) containing 1 µg/mL p-phenylenediamine (Sigma) and was imaged 232 
using a 100× oil immersion objective (Olympus IX-70). The filter set used was DA/FI/TX-3X-233 
A-OMF (Semrock). Fluorescence and phase contrast images were false colour merged using the 234 
Metamorph software program.  235 
 236 
MitoTracker® Red CMXRos labelling 237 
HeLa cells were seeded and infected as described in "Invasion assay and IF microscopy". The 238 
infected cells were washed thrice with D-PBS and incubated with 0.5 mL MEM containing 40 239 
µg/mL of gentamicin for 2 h 55 min. The media was removed and replaced with pre-warmed 400 240 
nM MitoTracker® Red CMXRos (Invitrogen) in MEM, 40 µg/mL gentamicin for 35 min. HeLa 241 
cells were washed thrice with pre-warmed D-PBS, fixed in pre-warmed 3.7% (v/v) formalin for 242 
15 min, followed by three washes with pre-warmed PBS. Bacteria and HeLa cell nuclei were 243 
stained with 10 μg/mL DAPI in MQ water for 1.5 min at RT, followed by two washes with pre-244 
warmed PBS and one wash with pre-warmed mQ water. Cover slips were mounted and imaged 245 
using a 100× oil immersion objective as described in "Invasion assay and IF microscopy". 246 
 247 
Protrusion formation 248 
HeLa cells were seeded, infected and fixed as per "Invasion assay and IF microscopy". HeLa 249 
cells were washed twice with 1× Annexin V binding buffer (99902; Biotium) prepared in milliQ 250 
(18.2 MΩ·cm) water, mounted on glass slides with the same buffer and were imaged using a 40× 251 
oil immersion objective (Olympus IX-70). Protrusion formation was defined as any extensions of 252 











bacterial projection(s) (minimum of a full bacterial length) beyond the periphery of the HeLa 253 
cell. For each condition in each experiment, a minimum of 100 cells were imaged. 254 
 255 
Assay for growth of intracellular bacteria  256 
HeLa cells (8 × 104) were seeded in 24-well trays in MEM, 10% FCS, 1% 257 
penicillin/streptomycin. Cells were grown to semi-confluence overnight, washed twice with D-258 
PBS and once with MEM, 10% FCS. 4 × 107 mid-exponential phase bacteria were added to each 259 
well (moi 500) and were centrifuged (2,000 rpm, 7 min, Heraeus Labofuge 400 R) onto HeLa 260 
cells. After 1 h incubation at 37°C, 5% CO2, the infected cells were washed thrice with D-PBS 261 
and incubated with 0.5 mL MEM containing 40 µg/mL of gentamicin. At the indicated intervals, 262 
monolayers (in duplicate) were washed four times in D-PBS and were lysed with 0.1% (v/v) 263 
Triton X-100 in PBS for 5 min and bacteria were enumerated on tryptic soy agar (TSA; Gibco) 264 
plates.  265 
 266 
LDH cytotoxicity assay  267 
HeLa cells (3 × 104) were seeded in 96-well trays in MEM, 10% FCS, 1% 268 
penicillin/streptomycin. Cells were grown to confluence overnight and were washed twice with 269 
PBS. 50 μL phenol-red free DMEM, 1 mM sodium pyruvate and 3 × 107 mid-exponential phase 270 
bacteria (moi 1000) in 50 μL PBS or PBS were added into each well, where appropriate. The 271 
bacteria were centrifuged (2,000 rpm, 7 min, Heraeus Labofuge 400 R) onto HeLa cells. After 1 272 
h incubation at 37°C, 5% CO2, the infected cells were washed thrice with PBS and incubated 273 
with 0.1 mL phenol-red free MEM, 40 µg/mL of gentamicin for 4 h. LDH activity was measured 274 
with the Cytotoxicity Detection KitPlus as per manufacturer's instructions (Roche). The 275 
percentage of LDH released was calculated with the following formula: ((experimental LDH 276 
release − spontaneous LDH release) / (maximal LDH − spontaneous LDH release)) × 100.  277 
 278 
Ethics statement  279 
The use of animals in this study has been approved by the University of Adelaide Animal Ethics 280 
Committee (Project number: S-2012-90). All animals used were handled in compliance with the 281 
Australian code of practice for the care and use of animals for scientific purposes, 7th edition 282 
(2004).  283 












Mouse Sereny test  285 
The mouse Sereny test (Murayama et al., 1986) was carried out as described previously (Lum et 286 
al., 2013). Male Balb/c mice (20-22g) were inoculated with 2.5 × 107 CFUs bacteria in 5 μL of 287 
bacterial suspension (in PBS) into the right eye; the left eye served as a diluent control. To 288 
ascertain the impact of Mdivi-1 on ocular infection, mice were injected intraperitoneally (IP) 289 
with drug at a dose rate of 30 mg/kg, at t = -1, +6, +23 and +30 hours with respect to infection at 290 
0 hours. Keratoconjunctivitis was evaluated at specific time points after inoculation and scored 291 
on a scale ranging from 0 (no infection), 1 (mild keratoconjuctivitis where the eye lid is slightly 292 
swollen), 2 (severe keratoconjuctivitis where the eye is half closed) and 3 (fully developed 293 
keratoconjunctivitis where the eye is completely closed). Due to an ethics concern with the in 294 
vivo  use of DMSO, Mdivi-1 was prepared in NMP/PEG, which is made up of 1 part 1-methyl-2-295 
pyrrolidione (NMP) and 9 parts polyethylene glycol 300 (PEG300). A preliminary mouse study 296 
showed that this dosing regime resulted in 10% weight loss over a period of 72 h (Fig. S1).   297 
 298 
Statistical analysis  299 
Statistical analysis was carried out using GraphPad Prism 6. Results are expressed as means ± 300 
SEM of data obtained in independent experiments. Statistical differences between two groups 301 
were determined with a two-tailed unpaired t-test. Statistical differences between three or more 302 
groups were determined with a one-way ANOVA followed by Tukey's multi comparison post 303 
hoc test. Statistical significance was set at p < 0.05.  304 
 305 
Results  306 
S. flexneri induces Drp1-mediated cell death in HeLa cells 307 
In a preliminary experiment, we investigated the effects of S. flexneri moi on LDH release. HeLa 308 
monolayers were infected with WT or virulence plasmid-cured (VP¯) S. flexneri at moi ranging 309 
from 1 - 1000 (Fig. S2). HeLa cells infected with WT Shigella at moi of ≥ 100 had significantly 310 
higher LDH release compared to the VP¯ strain. Moi of 500 and 1000 was used in this study to 311 
reflect the experimental conditions used previously (Lum et al., 2013). No difference in LDH 312 
release was observed between moi 500 and 1000 (Fig. S2). 313 
 314 











Recently we reported that dynasore, a non-competitive, reversible inhibitor of dynamin II and 315 
Drp1 GTPase activity significantly reduced S. flexneri-induced cytotoxicity in HeLa cells (Lum 316 
et al., 2013). The efficacy of dynasore was also tested in a murine ocular infection model. Mice 317 
treated with dynasore lost significantly less weight compared to mice treated with the NMP/PEG 318 
vehicle, however no improvement in ocular inflammation was observed. These results prompted 319 
us to examine the role of Drp1, if any, during S. flexneri pathogenesis. We initially investigated 320 
if S. flexneri-induced HeLa cytotoxicity was mediated by the mitochondrial fission protein, 321 
Drp1. The effects of Mdivi-1, a Drp1 inhibitor, and Drp1 siRNA on LDH release were 322 
determined. HeLa monolayers infected with S. flexneri (moi 1000) were treated with increasing 323 
concentrations of Mdivi-1 or with the DMSO control alone. Shigella-infected DMSO-treated 324 
HeLa cells released high levels of LDH (43.68 ± 0.85%). In HeLa cells treated with 50 μM 325 
Mdivi-1, LDH release was significantly reduced (32.70 ± 0.47%) and further reduction was 326 
observed with 100 μM Mdivi-1 treatment (24.06 ± 2.70) (Fig. 1A). To investigate the effect of 327 
Drp1 depletion on S. flexneri-induced cytotoxicity, HeLa cells were transfected with Drp1 328 
siRNA and LDH release by infected cells was measured. Western immunoblots of HeLa cell 329 
lysates two days post siRNA treatment showed no detectable Drp1 levels (Fig. 1B). LDH release 330 
induced by S. flexneri was significantly reduced in HeLa cells treated with Drp1 siRNA (*p < 331 
0.05) (Fig. 1C). 332 
 333 
S. flexneri induces non-apoptotic cell death in HeLa cells  334 
Since Drp1 have been implicated in both apoptosis and necrosis, we determined if components 335 
of the apoptotic or necrotic cell death pathways were involved. Uninfected HeLa monolayers 336 
were treated with the DMSO control or positive control agents; staurosporine (STS) to induce 337 
apoptosis or 0.01% Triton X-100 to induce necrosis (Kwon et al., 2011) (Fig. 2A). LDH release 338 
was observed in HeLa cells treated with 0.01% Triton X-100 but not STS. The effects of Z-339 
VAD-fmk, a pan-caspase inhibitor and its inactive analogue, Z-FA-fmk, on LDH release during 340 
S.flexneri infection were determined. HeLa monolayers infected with S. flexneri were treated 341 
with increasing concentrations of Z-VAD-fmk or Z-FA-fmk or the DMSO control. No reduction 342 
in LDH release was observed (Fig. 2B and 2C). Caspase-3 cleavage is indicative of apoptosis 343 
activation (Reed, 2000). We investigated activated caspase-3 localisation in untreated, DMSO-344 
treated, STS-treated and S. flexneri-infected (moi 500) HeLa cells (Fig. S3A - 3D). Activated 345 











caspase-3 was only observed in HeLa cells treated with STS (Fig. S3C). Nuclear and cell 346 
shrinkage was also observed. Therefore S. flexneri infection induced non-apoptotic cell death in 347 
HeLa cells. Since LDH release was observed when HeLa cells were treated with Triton X-100 348 
and not STS, we reasoned that the cell death pathway activated during Shigella infection under 349 
the conditions used is most likely necrosis. 350 
 351 
Next we investigated if components of the programmed necrosis pathway are important during S. 352 
flexneri-infection. Necrostatin-1 is an allosteric inhibitor of receptor-interacting Ser/Thr kinases 353 
1 (RIP1) (Degterev et al., 2008); necrostatin-7 targets an unknown effector in the programmed 354 
necrosis pathway (Zheng et al., 2008) and necrosulfonamide covalently modifies mixed lineage 355 
kinase domain-like protein (MLKL) to prevent downstream necrosis activation (Sun et al., 356 
2012). HeLa monolayers infected with S. flexneri (moi 1000) were treated with increasing 357 
concentrations of necrostatin-1 or necrostatin-7 or necrosulfonamide or with the DMSO control 358 
alone. No reduction in LDH release was observed (Fig. 2D, 2E and 2F). We also investigated if 359 
S. flexneri-induced cell death was a result of oxidative stress. IM-54 inhibits hydrogen peroxide-360 
induced necrosis (Dodo et al., 2005); and NecroX-2 and NecroX-5 are mitochondria-targeted 361 
ROS and nitrogen oxidative species (NOS) scavengers (Kim et al., 2010). HeLa monolayers 362 
infected with S. flexneri (moi 1000) were treated with increasing concentrations of IM-54 or 363 
NecroX-2 or NecroX-5 or with the DMSO control alone. No reduction in LDH release was 364 
observed (Fig. 2G and 2H). Hence S. flexneri-induced cell death in HeLa cells is unlikely a 365 
consequent of oxidative stress and is unlikely activated via the RIP1/MLKL programmed 366 
necrosis pathway.  367 
 368 
S. flexneri infection induces mitochondrial fragmentation 369 
Next we investigated the effects of S. flexneri infection on mitochondria of HeLa cells by IF 370 
microscopy. In uninfected and DMSO-treated HeLa cells, the mitochondrial network is long and 371 
tubular (Fig. 3A and 3B). When mitochondrial division is inhibited, tubular mitochondrial 372 
networks becomes interconnected to form net-like structures, or collapse into perinuclear 373 
structures (Smirnova et al., 2001; Smirnova et al., 1998). HeLa cells treated with the Drp1 374 
inhibitor, Mdivi-1, had degenerate perinuclear mitochondrial structures (Fig. 3C). HeLa cells 375 
were either untreated, treated with DMSO or treated with Mdivi-1, and were infected with S. 376 











flexneri (moi 500) for 3.5 hours. Infected HeLa cells treated with Mdivi-1 had significantly 377 
reduced mitochondrial fragmentation (17.26 ± 1.26%) compared to untreated (33.49 ± 3.40%) or 378 
DMSO-treated (30.88 ± 1.63%) HeLa cells (Fig. 3D - 3G). High bacterial loads were also 379 
observed in Shigella-infected HeLa cells regardless of treatment (Fig. 3D - 3F). 380 
 381 
The effect of Drp1 depletion on mitochondrial fragmentation during S. flexneri infection was 382 
determined. HeLa cells were mock transfected or transfected with either negative siRNA or Drp1 383 
siRNA, and were infected with S. flexneri (moi 500) for 3.5 hours. Drp1-depleted HeLa cells had 384 
significantly reduced mitochondrial fragmentation (15.94 ± 2.55%) compared with mock-385 
transfected (27.65 ± 0.38%) or negative siRNA-treated (27.88 ± 0.10%) HeLa cells during 386 
Shigella infection (Fig. 4A - 4D). No differences in bacterial loads were observed in infected 387 
cells regardless of treatment. Therefore S. flexneri infection in HeLa cells increased Drp1 388 
dependent mitochondrial fragmentation.  389 
 390 
Drp1 is important for S. flexneri cell to cell spreading but not protrusion formation 391 
Dynasore, an inhibitor of dynamin II and Drp1 GTPase reduced S. flexneri cell to cell spreading. 392 
Dynamin II knockdown with siRNA also significantly affected S. flexneri infectious foci 393 
formation (Lum et al., 2013). We decided to investigate if Drp1 also played a role during S. 394 
flexneri cell to cell spreading. The effects of Mdivi-1 and Drp1 siRNA on infectious foci or 395 
plaque formation by S. flexneri were determined. Initial experiment showed that Mdivi-1 could 396 
not be used in the plaque assay due to precipitation when dissolved in the agar mixture. HeLa 397 
monolayers infected with S. flexneri (moi 0.1) were treated with increasing concentrations of 398 
Mdivi-1 in an infectious focus assay. Treatment with 20 µM Mdivi-1 reduced foci counts and 399 
foci area (*p < 0.05) (Fig. 5A - 5C). To investigate the effect of Drp1 depletion on S. flexneri cell 400 
to cell spreading, HeLa cells were transfected with Drp1 siRNA and plaque assay was carried 401 
out. S. flexneri formed plaques on HeLa cells treated with Drp1 siRNA with a reduced plaque 402 
diameter but not plaque counts when compared to HeLa cells treated with the negative control 403 
siRNA (*p < 0.05) (Fig. 6A - 6C). Therefore Drp1 inhibition with Mdivi-1 as well as siRNA 404 
knockdown reduced Shigella cell to cell spreading.  405 
 406 











Reduced or absence of protrusion formation may account for decreased infectious focus and 407 
plaque formation. The role of Drp1 in S. flexneri protrusion formation was investigated. HeLa 408 
monolayers infected with S. flexneri were treated with the DMSO control or 50 μM Mdivi-1 and 409 
the percentage of infected cells with one or more bacteria protrusions were enumerated by 410 
counting >100 cells in each experiment (Fig. 7A and 7B). 55.40 ± 1.48% of infected HeLa cells 411 
had one or more protrusions. Protrusion formation was not affected by the DMSO control (55.27 412 
± 2.89%) or 50 μM Mdivi-1 (53.51 ± 0.06%). Reduced S. flexneri intracellular growth could also 413 
account for the reduction in focus area and plaque size, but no differences in bacterial counts 414 
were observed between DMSO and Mdivi-1-treated HeLa cells (Fig. S4). 415 
 416 
Drp1 is not localised to the F-actin tails 417 
Host proteins have been shown to associate with S. flexneri actin tail (Kadurugamuwa et al., 418 
1991; Lum et al., 2013; Sansonetti et al., 1994). We investigated Drp1 localisation in S. flexneri-419 
infected HeLa cells by IF microscopy. Drp1 was not localised to the S. flexneri actin tail in 420 
untreated, DMSO-treated, Mdivi-1-treated or Drp1 siRNA-treated HeLa cells (Fig. 8A - 8D).  421 
 422 
Effect of Mdivi-1 on S. flexneri infection of mice 423 
We next investigated the possible in vivo relevance of the observed association between Drp1 424 
and S. flexneri cytotoxicity as well as cell to cell spreading. A mouse Sereny test we established 425 
previously (Lum et al., 2013) was used to determine whether ocular infection by S. flexneri could 426 
be inhibited by the administration of Mdivi-1. Mice in two groups were injected IP with Mdivi-1 427 
(30 mg/kg) or vehicle at t = -1, 6, 23 and 30 h, and infected with 2.5 × 107 CFUs S. flexneri 428 
2457T in the right eye (t = 0). The mice in both groups developed ocular inflammation at a 429 
similar rate and the Sereny scores were similar (Fig. S5A and S5B). Although a slight effect on 430 
weight loss was observed on D1, no differences were observed on D2 and D3 (Fig. S5C).  431 
 432 
Discussion 433 
Shigella infection in epithelial cells is an interplay between maintaining a replicative niche for 434 
Shigella and elimination of infected cells to prevent further cell spreading, even though cell 435 
death and the ensuing inflammation are at considerable cost to the host (Ashida et al., 2011). 436 
During Shigella infection, apoptotic (Lembo-Fazio et al., 2011) or necrotic cell death 437 











(Bergounioux et al., 2012; Carneiro et al., 2009; Kobayashi et al., 2013) occurs depending on the 438 
experimental conditions. In both cases changes to the outer or inner mitochondrial membrane are 439 
critical to allow the respective cell death pathways to proceed. In this study we investigated the 440 
role of Drp1, the mitochondrial fission protein, during Shigella infection in HeLa cells. Shigella 441 
infection for 4 hours at moi 1000 induces high levels of LDH release. Inhibition of Drp1 with 442 
Mdivi-1 as well as Drp1 depletion with siRNA significantly reduced HeLa cell cytotoxicity.  443 
 444 
Drp1 is recruited to the mitochondria during apoptosis and programmed necrosis. During 445 
apoptosis, pro-apoptotic Bax localises to the outer membrane (OM) of the mitochondria and 446 
colocalises with Mfn2 and activates Drp1 at fission sites (Wasiak et al., 2007). Following 447 
mitochondrial fragmentation, mitochondrial OM permeabilisation (MOMP) and cristae 448 
reorganisation, cytochrome c is released and caspases are subsequently activated (Frank et al., 449 
2001). Upon programmed necrosis induction by tumour necrosis factor-α (TNF-α), RIP1 and 450 
RIP3 interacts with MLKL (Wang et al., 2012). The RIP1/RIP3/MLKL complex is translocated 451 
to the mitochondria to engage mitochondrial protein phosphatase long variant (PGAM5L) 452 
initially and subsequently PGAM5S (PGAM short variant) on the mitochondrial membrane. 453 
Drp1 GTPase activity is activated via dephosphorylation at Ser637, likely by both PGAM5L and 454 
PGAM5S in situ on the mitochondrial OM (Wang et al., 2012). It is speculated Drp1 activation 455 
may cause mitochondrial fragmentation resulting in reduced ATP production, ROS generation or 456 
other downstream events (Wang et al., 2012). 457 
 458 
We next investigated if components of apoptosis or programmed necrosis are activated during 459 
Shigella infection. HeLa cells treated with STS to induce apoptosis resulted in caspase-3 460 
activation as expected (Nicolier et al., 2009), but no significant LDH release was detected in the 461 
culture supernatant. Unsurprisingly pan-caspase inhibition with Z-VAD-fmk or its inactive 462 
analogue, Z-FA-fmk did not affect LDH release in Shigella-infected HeLa cells. Inhibition of 463 
programmed necrosis components such RIP1 and MLKL did not reduce LDH release during 464 
Shigella infection. ROS and NOS inhibitors also had no effect on LDH release. During Shigella 465 
infection (moi 500, 3.5 h), mitochondrial fragmentation was observed in ~ 30% of HeLa cells. 466 
Mitochondrial fragmentation in infected HeLa cells was halved when Drp1 was inhibited with 467 
Mdivi-1 or depleted with siRNA. Previously mitochondrial fragmentation was not observed 468 











when HeLa cells were infected with Shigella for 1 h at moi 50 (Stavru et al., 2011). In that study 469 
t = 1 h refers to the 1 h infection time prior to incubation with 80 μg/mL gentamicin to remove 470 
extracellular bacteria. In our study the equivalent time point is t = 0. Collectively data from the 471 
previous study and our observations showed during Shigella infection, mitochondrial 472 
fragmentation occurs at a later time point and/or at a much higher moi. In spite of the high 473 
bacterial load, HeLa cells remain intact and alive, similar to observations reported earlier (Mantis 474 
et al., 1996).  475 
 476 
Overall our results suggest that at high moi, Shigella infection induces non-apoptotic HeLa cell 477 
death which is mediated by Drp1 and accompanied by mitochondrial fragmentation. Furthermore 478 
HeLa cell death induction during Shigella infection is also not dependent on the RIP1/MLKL 479 
programmed necrosis pathway. Previously hallmarks of necrosis such as loss of mitochondrial 480 
inner potential, nuclear and plasma membrane swelling were observed at 8 h post infection in 481 
MEFs infected with Shigella (strain M90T) at moi 100 (C rneiro et al., 2009). ROS generation 482 
was also observed 10 h post infection (Carneiro et al., 2009). Consistent with previous finding, 483 
ROS scavengers had no effect on LDH release at 4 h post infection in this study. Mitochondrial 484 
swelling was reported in HaCat cells infected with S. flexneri strain YSH6000 at moi 25 for 2 h 485 
(Kobayashi et al., 2013). Changes to mitochondrial morphology observed previously might now 486 
be attributed to Drp1-mediated mitochondrial fragmentation.  487 
 488 
Mitochondrial fission during host cell death in other bacterial infections have been reported, 489 
although Drp1 involvment is not essential. The pore-forming vacuolating cytotoxin A (VacA) 490 
toxin of the gastric pathogen, Helicobacter pylori, recruits and activates Drp1 resulting in 491 
mitochondrial fission, Bax activation, MOMP and cytochrome c release (Jain et al., 2011). Drp1 492 
fission however is not a prerequisite for VacA-mediated MOMP (Jain et al., 2011). Another 493 
pore-forming toxin, listeriolysin O (LLO) from Listeria monocytogenes, the causative agent of 494 
food-borne listeriosis, was reported to fragment mitochondrial networks in HeLa cells, followed 495 
by subsequent decrease in the mitochondrial membrane potential and ATP levels (Stavru et al., 496 
2011). Intriguingly the Drp1 receptor, Mff, is degraded resulting in reduced Drp1 at the 497 
mitochondria following Listeria infection or LLO treatment but mitochondrial fission is not 498 
disrupted (Stavru et al., 2013). It appears the endoplasmic reticulum and the actin cytoskeleton 499 











facilitates mitochondrial fission independent of Drp1, although the exact mechanism is not 500 
known.  501 
 502 
Earlier we reported dynasore treatment and dynamin II knockdown with siRNA reduced Shigella 503 
cell spreading in HeLa cells (Lum et al., 2013). Dynasore is a non-competitive, reversible 504 
inhibitor of dynamin II and Drp1 GTPase activity. We decided to investigate Drp1's role, if any, 505 
in Shigella infectious focus and plaque formation. Drp1 inhibition with Mdivi-1 reduced Shigella 506 
cell spreading in a dose dependant manner and Drp1 knockdown with siRNA also reduced 507 
Shigella plaque size. Previously Drp1 was reported to colocalise with F-actin stress fibers in 508 
Cos-1 cells, an immortalized mammalian fibroblastic cell line (DuBoff et al., 2012). We did not 509 
observe any interactions between Drp1 and either the F-actin cytoskeleton or the Shigella F-actin 510 
tail via IF microscopy in this study. High levels of Drp1 were detected by microscopy in Cos-1 511 
cells (DuBoff et al., 2012), however low levels of Drp1 was observed in HeLa cells in our study. 512 
Hence it is possible Drp1 recruitment to HeLa cell F-actin cytoskeleton and/or Shigella F-actin 513 
tail may not be evident due to technical limitations. 514 
 515 
A study in Potoroo tridactylis kidney epithelial (PtK2) cells showed that Listeria cell spreading 516 
in areas with high mitochondrial density (perinuclear region) had increased mean speed and 517 
greater curvature in trajectories compared to areas with low mitochondrial density (cell 518 
periphery) (Lacayo and Theriot, 2004). Listeria and Shigella both mediate actin based motility 519 
for cell spreading (Gouin et al., 2005). Inhibition of Drp1 forms net-like mitochondrial networks, 520 
which can collapse into perinuclear structures (Smirnova et al., 2001; Smirnova et al., 1998). 521 
Hence Mdivi-1 treatment would alter the intracellular millieu of HeLa cells dramatically, such 522 
that Shigella intracellular speed and movement would be adversely affected. In Mdivi-1 treated 523 
cells, F-actin comet tail formation, intracellular bacterial growth and protrusion formation was 524 
not affected. Hence Shigella protrusion formation is not likely to be dependent on its intracellular 525 
motility. Lacoya and Theriot (2004) also observed that MitoTracker Red-labeled mitochondria 526 
had loss of fluorescent label post Listeria collision, presumably due to loss of mitochondrial 527 
integrity and transmembrane potential. In this study, we also noticed on some occasions that 528 
MitoTracker Red labeling was more intense in uninfected HeLa cells compared to infected cells. 529 
 530 











Since Mdivi-1 was able to reduce Shigella cell spreading and HeLa cell cytotoxicity, the drug's 531 
efficacy was tested in vivo in a murine keratoconjunctivitis (Sereny) model we used previously 532 
(Lum et al., 2013). However Mdivi-1 treatment did not ameliorate conjunctivitis, at least under 533 
the dosing protocol used in these studies. Since an ∆icsA mutant is not pathogenic in this model 534 
(Lum et al., 2013), this suggest that Mdivi-1 does not significantly impair intercellular spreading 535 
in vivo. It is possible that the dosing regime used here was not sufficient to maintain an effective 536 
concentration of drug in vivo.   537 
 538 
In conclusion, Drp1 and mitochondrial dynamics play important roles in different aspects of 539 
Shigella pathogenesis. During Shigella infection, mitochondrial fission following cell death 540 
pathway activation is important to eliminate infected cells. Furthermore loss of mitochondrial 541 
networks disrupts Shigella's ability to mediate cell spreading. Loss of mitochondrial structure 542 
may have altered the intracellular movement of Shigella. Although Shigella protrusion formation 543 
was not affected, the inefficient intracellular movement over an extended period of time in the 544 
duration of both the infectious focus and plaque assay may retard Shigella's movement from one 545 
cell to the next, resulting in reduced infectious focus area and plaque size. Since the conditions 546 
used to study cell death and cell spreading differ necessarily in HeLa cell confluency, moi and 547 
time of infection, it is difficult to speculate if there are any correlations between cell death, cell 548 
spreading and mitochondrial structure. Future work should focus on how Drp1 is recruited and 549 
activated during Shigella infection and if disruption of mitochondrial dynamics would also affect 550 
other bacteria which rely on actin based motility for host dissemination.    551 
 552 
Acknowledgements 553 
We are grateful to Dr. Stephen R. Attridge for assistance with the mouse studies. This work is 554 
supported by a Program Grant (565526) from the National Health and Medical Research Council 555 




























Carneiro,  L.A.M., Travassos,  L.H., Soares, F., Tattoli,  I., Magalhaes,  J.G., Bozza, M.T., Plotkowski, M.C., 573 
Sansonetti,  P.J.,  Molkentin,  J.D.,  Philpott,  D.J.,  Girardin,  S.E.,  2009.  Shigella  Induces  Mitochondrial 574 
Dysfunction and Cell Death in Nonmyleoid Cells. Cell Host & Microbe 5, 123‐136. 575 
Cassidy‐Stone,  A.,  Chipuk,  J.E.,  Ingerman,  E.,  Song,  C.,  Yoo,  C.,  Kuwana,  T.,  Kurth,  M.J.,  Shaw,  J.T., 576 
Hinshaw, J.E., Green, D.R., Nunnari, J., 2008. Chemical  inhibition of the mitochondrial division dynamin 577 
reveals  its  role  in Bax/Bak‐dependent mitochondrial outer membrane permeabilization. Dev. Cell  14, 578 
193‐204. 579 





Dodo, K., Katoh, M.,  Shimizu, T., Takahashi, M.,  Sodeoka, M., 2005.  Inhibition of hydrogen peroxide‐585 
induced necrotic cell death with 3‐amino‐2‐indolylmaleimide derivatives. Bioorg. Med. Chem. Lett. 15, 586 
3114‐3118. 587 
DuBoff,  B., Götz,  J.,  Feany, Mel B.,  2012.  Tau  Promotes Neurodegeneration  via DRP1 Mislocalization 588 
In Vivo. Neuron 75, 618‐632. 589 





























Jain, P.,  Luo, Z.‐Q., Blanke,  S.R., 2011. Helicobacter pylori  vacuolating  cytotoxin A  (VacA) engages  the 608 










Antagonizes  Inflammatory Cell Death, and Promotes Epithelial  Infection. Cell Host & Microbe 13, 570‐619 
583. 620 
Korobova,  F., Ramabhadran, V., Higgs, H.N.,  2013. An Actin‐Dependent  Step  in Mitochondrial  Fission 621 
Mediated by the ER‐Associated Formin INF2. Science 339, 464‐467. 622 








virG,  a  plasmid‐coded  virulence  gene  of  Shigella  flexneri:  identification  of  the  virG  protein  and 631 
determination of the complete coding sequence. J. Bacteriol. 171, 353‐359. 632 






Morona,  R.,  Daniels,  C.,  Van  Den  Bosch,  L.,  2003.  Genetic  modulation  of  Shigella  flexneri  2a 639 
lipopolysaccharide  O  antigen  modal  chain  length  reveals  that  it  has  been  optimized  for  virulence. 640 
Microbiol. 149, 925‐939. 641 






of  caspase‐dependent  and  ‐independent  pathways  in  staurosporine‐induced  apoptosis  of  p53wt  and 648 
p53mt human cervical carcinoma cells. Biol. Cell. 101, 455‐467. 649 
Oaks,  E.V., Wingfield, M.E.,  Formal,  S.B.,  1985.  Plaque  formation  by  virulent  Shigella  flexneri.  Infect. 650 
Immun. 48, 124‐129. 651 
























Sansonetti, P.J., Ryter, A., Clerc, P., Maurelli, A.T., Mounier,  J., 1986. Multiplication of Shigella  flexneri 665 
within  HeLa  cells:  lysis  of  the  phagocytic  vacuole  and  plasmid‐mediated  contact  hemolysis.  Infect. 666 
Immun. 51, 461‐469. 667 
Schuch, R., Sandlin, R.C., Maurelli, A.T., 1999. A system for identifying post‐invasion functions of invasion 668 
genes:  requirements  for  the  Mxi‐Spa  type  III  secretion  pathway  of  Shigella  flexneri  in  intercellular 669 
dissemination. Mol. Microbiol. 34, 675‐689. 670 
Senerovic, L., Tsunoda, S.P., Goosmann, C., Brinkmann, V., Zychlinsky, A., Meissner, F., Kolbe, M., 2012. 671 
Spontaneous  formation  of  IpaB  ion  channels  in  host  cell  membranes  reveals  how  Shigella  induces 672 
pyroptosis in macrophages. Cell Death Dis. 3, e384. 673 
Smirnova,  E., Griparic,  L.,  Shurland, D.‐L.,  van der Bliek, A.M., 2001. Dynamin‐related Protein Drp1  Is 674 
Required for Mitochondrial Division in Mammalian Cells. Mol. Biol. Cell 12, 2245‐2256. 675 
Smirnova,  E.,  Shurland, D.‐L., Ryazantsev,  S.N.,  van  der Bliek, A.M.,  1998. A Human Dynamin‐related 676 
Protein Controls the Distribution of Mitochondria. J. Cell Biol. 143, 351‐358. 677 
Stavru,  F., Bouillaud,  F.,  Sartori, A., Ricquier, D., Cossart, P., 2011.  Listeria monocytogenes  transiently 678 
alters mitochondrial dynamics during infection. Proc. Natl. Acad. Sci. U. S. A. 108, 3612‐3617. 679 





Suzuki,  T.,  Franchi,  L.,  Toma,  C.,  Ashida,  H.,  Ogawa,  M.,  Yoshikawa,  Y.,  Mimuro,  H.,  Inohara,  N., 685 
Sasakawa, C., Nunez, G., 2007. Differential regulation of caspase‐1 activation, pyroptosis, and autophagy 686 
via Ipaf and ASC in Shigella‐infected macrophages. PLoS Pathog. 3, e111. 687 
Tang, W.X., Wu, W.H., Qiu, H.Y., Bo, H., Huang,  S.M.,  2013. Amelioration of  rhabdomyolysis‐induced 688 
renal mitochondrial  injury  and  apoptosis  through  suppression  of Drp‐1  translocation.  J. Nephrol.  26, 689 
1073‐1082. 690 
Tran Van Nhieu, G., Clair, C., Bruzzone, R., Mesnil, M., Sansonetti, P., Combettes,  L., 2003. Connexin‐691 
dependent  inter‐cellular  communication  increases  invasion  and dissemination of  Shigella  in epithelial 692 
cells. Nat. Cell Biol. 5, 720‐726. 693 




Wasiak,  S.,  Zunino,  R.,  McBride,  H.M.,  2007.  Bax/Bak  promote  sumoylation  of  DRP1  and  its  stable 698 
association with mitochondria during apoptotic cell death. J. Cell Biol. 177, 439‐450. 699 
Willingham, S.B., Bergstralh, D.T., O'Connor, W., Morrison, A.C., Taxman, D.J., Duncan, J.A., Barnoy, S., 700 
Venkatesan, M.M.,  Flavell, R.A., Deshmukh, M., Hoffman, H.M.,  Ting,  J.P.,  2007. Microbial pathogen‐701 
induced  necrotic  cell  death mediated  by  the  inflammasome  components CIAS1/cryopyrin/NLRP3  and 702 
ASC. Cell Host Microbe 2, 147‐159. 703 




























Figure 1. Drp1 mediates S. flexneri 2457T-induced HeLa cell death. (A) HeLa cells were 709 
infected with S. flexneri 2457T (moi 1000) in a 96-well tray for 1 h, followed by incubation with 710 
MEM containing 40 µg/mL of gentamicin to exclude extracellular bacteria for 4 h as described 711 
in the Methods. LDH release was measured in the presence of DMSO or Mdivi-1. Data are 712 
represented as mean ± SEM of independent experiments (n = 3), analysed with one-way 713 
ANOVA (p < 0.0001), followed by Tukey's post hoc test (*p < 0.05, ***p < 0.001, ****p < 714 
0.0001). No differences in LDH release were observed in the presence of Mdivi-1 or DMSO in 715 
the absence of bacterial infection (B - C) HeLa cells were either mock transfected or transfected 716 
with control or Drp1 siRNA for 24 h, trypsinised and re-transfected for further 24 h. (B) HeLa 717 
cell extracts were probed with anti-Drp1. GAPDH was used as a loading control. (C) Post 718 
transfection, HeLa cells were infected with S. flexneri 2457T in a 96-well tray as described in 719 
(A). Data are represented as mean ± SEM of independent experiments (n = 2), analysed with 720 
one-way ANOVA (p = 0.0129), followed by Tukey's post hoc test (*p < 0.05). 721 
 722 
Figure 2. S. flexneri 2457T induces non-apoptotic cell death in HeLa cells. HeLa cells were 723 
infected with S. flexneri 2457T (moi 1000) in a 96-well tray for 1 h, followed by incubation with 724 
MEM containing 40 µg/mL of gentamicin to exclude extracellular bacteria for 4 h as described 725 
in the Methods. LDH release was measured in the presence of DMSO or (A) Staurosporine 726 
(STS) or 0.01% Triton X-100, (B) Z-VAD-fmk, (C) Z-FA-fmk, (D) Necrostatin-1, (E) 727 
Necrostatin-7, (F) Necrosulfonamide, (G) IM-54, (H) NecroX-2 or NecroX-5. Data are 728 
represented as mean ± SEM of independent experiments (n = 3). (B) - (H) were analysed with 729 
one-way ANOVA (p = 0.0495 for Z-VAD-fmk, p > 0.05 for Z-FA-fmk, p = 0.0073 for 730 
Necrostatin-1, p = 0.0458 for Necrostatin-7, p > 0.05 for Necrosulfonamide, p = 0.0193 for IM-731 
54, and p > 0.05 for NecroX-2 and NecroX-5), followed by Tukey's post hoc test. No differences 732 
in LDH release were observed in the presence of the specific chemicals or DMSO in the absence 733 
of bacterial infection. 734 
 735 
Figure 3. Drp1 inhibition with Mdivi-1 reduces mitochondrial fragmentation in HeLa cells 736 
during S. flexneri 2457T infection. HeLa cells were infected with S. flexneri 2457T (moi 500) 737 











for 1 h, followed by  incubation with MEM containing 40 µg/mL of gentamicin to exclude 738 
extracellular bacteria for 3.5 h as described in the Methods. Bacteria and HeLa nuclei were 739 
stained with DAPI and mitochondria was stained with MitoTracker® Red CMXRos. Images 740 
were taken at 100× magnification. Scale bar = 10 μm. The last column is 2.5× magnifications of 741 
the respective boxed areas in the MitoTracker® Red CMXRos images. (A) - (F) Uninfected or  742 
2457T-infected HeLa cells were treated with DMSO or Mdivi-1; (A) HeLa; (B) HeLa + DMSO; 743 
(C) HeLa + 50 μM Mdivi-1; (D) 2457T; (E) 2457T + DMSO ; (F) 2457T + 50 μM Mdivi-1. (G) 744 
The percentage of cells with fragmented mitochondria was determined by counting >100 cells in 745 
each experiment. Data are represented as mean ± SEM of independent experiments (n = 2), 746 
analysed with one-way ANOVA (p = 0.0289), followed by Tukey's post hoc test (*p < 0.05). 747 
 748 
Figure 4. Transfection of HeLa cells with Drp1 siRNA reduces mitochondrial 749 
fragmentation in HeLa cells during S. flexneri 2457T infection. HeLa cells were either mock 750 
transfected or transfected with control or Drp1 siRNA for 24 h, trypsinised and re-transfected for 751 
further 24 h. HeLa cells were infected with S. flexneri 2457T (moi 500) for 1 h, followed by  752 
incubation with MEM containing 40 µg/mL of gentamicin to exclude extracellular bacteria for 753 
3.5 h as described in the Methods. Bacteria and HeLa nuclei were stained with DAPI and 754 
mitochondria was stained with MitoTracker® Red CMXRos. Images were taken at 100× 755 
magnification. Scale bar = 10 μm. The last column is 2.5× magnifications of the respective 756 
boxed areas in the MitoTracker® Red CMXRos images. (A) - (C) Mock, control siRNA and 757 
Drp1 siRNA transfected HeLa cells were infected with 2457T; (A) Mock transfected; (B) 758 
Control siRNA; (C) Drp1 siRNA. (D) The percentage of cells with fragmented mitochondria was 759 
determined by counting >100 cells in each experiment. Data are represented as mean ± SEM of 760 
independent experiments (n = 2), analysed with one-way ANOVA (p < 0.0001), followed by 761 
Tukey's post hoc test (*p < 0.05). 762 
 763 
Figure 5. Drp1 inhibition with Mdivi-1 reduces S. flexneri MLRM107 foci counts and foci 764 
area. HeLa cells were infected with S. flexneri MLRM107 in an infectious focus assay using a 765 
12-well tray as described in the Methods. Infectious foci were imaged 24 h post gentamicin 766 
treatment. (A) Images shown are overlay of an image taken with phase contrast and TxRed filter 767 
(10× magnification). The area of the infectious focus i.e. area where mCherry was detected, is 768 











outlined. Scale bar = 0.1 mm. (B) The total foci counts from one well or (C) mean foci area from 769 
one well were calculated. Data are represented as mean ± SEM of independent experiments (n = 770 
3), analysed with one-way ANOVA (p = 0.0013 for foci counts and p = 0.0003 mean foci area), 771 
followed by Tukey's post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001). 772 
 773 
Figure 6. HeLa cells transfected with Drp1 siRNA reduces S. flexneri 2457T plaque size. 774 
HeLa cells were either mock transfected or transfected with control or Drp1 siRNA for 24 h, 775 
trypsinised and re-transfected for further 24 h. HeLa cells were infected with S. flexneri 2457T in 776 
a plaque assay using a 6-well tray as described in the Methods. (A) Wells were stained with 777 
Neutral Red to makes plaques more visible. Scale bar = 2 mm. (B) The total plaque counts or (C) 778 
mean plaque diameters from each well infected with Shigella were calculated. Data are 779 
represented as mean ± SEM of independent experiments (n = 2), analysed with one-way 780 
ANOVA (p > 0.05 for plaque counts and p = 0.0239 mean plaque diameters), followed by 781 
Tukey's post hoc test (*p < 0.05). 782 
 783 
Figure 7. S. flexneri 2457T protrusion is not affected in the presence of Mdivi-1. HeLa cells 784 
were infected with S. flexneri 2457T for 1 h in a 24-well tray. HeLa cells were washed thrice 785 
with D-PBS and incubated with MEM containing 40 µg/mL of gentamicin (t=0) to exclude 786 
extracellular bacteria. Concurrently HeLa cells were treated with 50 μM Mdivi-1 or DMSO for 787 
1.5 h. At t = 1.5, HeLa cells were fixed to observe bacteria protrusions. (A) Infected HeLa cells 788 
were imaged at 40× magnification. Scale bar = 10 μm. The arrows indicate protrusion formation. 789 
Insert shows 2× enlargement of the indicated region. (B) The percentage of infected cells with 790 
bacteria protrusion(s) were enumerated by counting >100 cells in each independent experiment.  791 
Data are represented as mean ± SEM of independent experiments (n = 2), analysed with one-way 792 
ANOVA (p > 0.05). 793 
 794 
Figure 8. Drp1 is not localised to the S. flexneri 2457T F-actin tails. HeLa cells were infected 795 
with S. flexneri 2457T in an invasion assay as described in the Methods. Bacteria and HeLa 796 
nuclei were stained with DAPI (blue), F-actin was stained with FITC-phalloidin (green) and 797 
Drp1 was stained with anti-Drp1 and Alexa Fluor 594-conjugated secondary antibody (red). 798 
Images were taken at 100× magnification. Scale bar = 10 μm.  (A) - (D) HeLa cells were treated 799 











with DMSO, Mdivi-1 or were transfected with Drp1 siRNA and were infected with S. flexneri 800 
2457T; (A) Untreated; (B) 1% DMSO; (C) 50 μM Mdivi-1; (D) Drp1 siRNA transfected HeLa 801 
cells. Arrows indicate F-actin comet tails. The experiment was repeated twice and representative 802 





























































































Table 1. Bacterial strains  1 
Strain  Relevant characteristics
#
 Reference or source 
S. flexneri   
2457T S. flexneri 2a wild type Laboratory 
collection 
MLRM107 2457T [pMP7604; Tc
R
] (Lum et al., 2013) 




, Tetracycline resistant 2 
 3 
Lum, M., Attridge, S.R., Morona, R., 2013. Impact of Dynasore an Inhibitor of Dynamin II on Shigella 4 
flexneri Infection. PLoS One 8, e84975. 5 
 6 
 7 
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